Menu
Recruiting NCT06699251

Effectiveness of Brief Intervention in Primary Care for Diverse Young People (Chat)

No phase Interventional Adolescent Drinking Cannabis Use

For patients and families

In plain language

An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.

What is being studied
The protocol lists: Chat, Enhanced Usual Care.
Who it may be relevant to
Registry conditions: Adolescent Drinking, Cannabis Use. Basic parameters: 12 years — 19 years · All.
What needs checking
Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
Where it takes place
United States
Next step
Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →
Official title

Effectiveness of Brief Intervention in Primary Care for Diverse Young People

Overview

Brief motivational interviewing intervention to address alcohol use among diverse teens 12-17.

Detailed description

The six-item CRAFFT will be used to screen teens at our partner clinics for risky AC use. For those that screen in as at-risk and express interest in the study, the teen's case manager will complete an online consent/assent form with the parent and teen that contains contact information for the teen so that investigators can follow up with the teen for surveys and intervention delivery or for providing an informational brochure. When the online consent/assent form is completed, the teen will be sent a personalized link to complete their baseline survey. Upon survey completion, the teen will receive a link that has their electronic gift card payment, and the case manager will be notified that a particular ID has completed the survey. The case manager will be informed by study staff whether to schedule that ID for enhanced usual care (EUC) or the Chat intervention. Investigators expect each teen to be scheduled within 30 days of completing their baseline survey to receive EUC or Chat. The informational brochure for the EUC will be handed to the teen during the visit or securely emailed, and Chat could take place either via a virtual or in-person visit. Whether or not the teen completes EUC or Chat, every teen will be followed by the RAND Survey Research Group to complete their follow-up web-based surveys based on timing of completion of their baseline survey. Teens will receive gift card incentives for completing the 3-month, 6-month, and 12-month surveys. Investigators will begin recruitment in month 9 of the project. Briefly, investigators expect to recruit from study month 9 to month 42 for the baseline survey. Investigators expect the Chat intervention to occur from months 9 to 42 the 3-month follow-up from months 12 to 45, 6-month from months 15 to 48, and the 12-month from months 21 to 53. Out of an anticipated 5,644 clients that our partner clinics will screen, investigators expect approximately 847 (15%) to screen in as at-risk on the CRAFFT and anticipate that approximately 500 (\~60%) will consent into the study.

Interventions

  • Behavioral Chat
    Chat is a brief motivational interviewing intervention for partner clinic participants with an alcohol or cannabis use condition.
  • Behavioral Enhanced Usual Care
    An informational brochure will be give to partner clinic participants with an alcohol or cannabis use condition.

Primary outcome measures

  • Alcohol - change in frequency of use [Time frame: Baseline to 3 months]
  • Alcohol - change in frequency of use [Time frame: 3 months to 6 months]
  • Alcohol - change in frequency of use [Time frame: 6 months to 12 months]
  • Cannabis - change in frequency of use [Time frame: Baseline to 3 months]
  • Cannabis - change in frequency of use [Time frame: 3 months to 6 months]
  • Cannabis - change in frequency of use [Time frame: 6 months to 12 months]
  • Alcohol - change in consequences of use [Time frame: Baseline to 3 months]
  • Alcohol - change in consequences of use [Time frame: 3 months to 6 months]
  • Alcohol - change in consequences of use [Time frame: 6 months to 12 months]
  • Cannabis - change in consequences of use [Time frame: Baseline to 3 months]
Secondary outcome measures (12)
  • Alcohol - change in time spent around peers [Time frame: Baseline to 3 months]
  • Alcohol - change in time spent around peers [Time frame: 3 months to 6 months]
  • Alcohol - change in time spent around peers [Time frame: 6 months to 12 months]
  • Cannabis - change in time spent around peers [Time frame: Baseline to 3 months]
  • Cannabis - change in time spent around peers [Time frame: 3 months to 6 months]
  • Cannabis - change in time spent around peers [Time frame: 6 months to 12 months]
  • Alcohol - change in motivation to change use [Time frame: Baseline to 3 months]
  • Alcohol - change in motivation to change use [Time frame: 3 months to 6 months]
  • Alcohol - change in motivation to change use [Time frame: 6 months to 12 months]
  • Cannabis - change in motivation to change use [Time frame: Baseline to 3 months]
  • Cannabis - change in motivation to change use [Time frame: 3 months to 6 months]
  • Cannabis - change in motivation to change use [Time frame: 6 months to 12 months]

Eligibility criteria

Inclusion criteria

  • receive health care at one of two participating health systems
  • aged 12-17
  • screen positive for being at risk for alcohol or cannabis use using the CRAFFT

Exclusion criteria

  • if they don't meet the inclusion criteria, they will be excluded

Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.

Healthy volunteers: Yes

Study design

Allocation
Randomized
Model
Parallel assignment
Masking
Open label
Primary purpose
Prevention

Study locations

United States · 2 centers
  • AltaMed Health Services — Commerce
  • University of Pittsburgh Medical Center Children's Hospital — Pittsburgh

Identifiers

NCT: NCT06699251 · 2024-N0065

Primary sources (government registries)

View this study on ClinicalTrials.gov ↗